Abstract:Adenovirus-mediated transient expression of the pancreatic duodenal homeobox transcription factor Pdx1 in mouse liver activates pancreatic endocrine and exocrine genes, the latter reportedly resulting in severe hepatitis. Expression of a super-active form of Pdx1 or Pdx1-VP16 selectively transdifferentiates hepatic WB cells into functional pancreatic beta-like insulin-producing cells, without evidence of exocrine differentiation. No study has systematically compared the transdifferentiation efficiency of Pdx1 and Pdx1-VP16 at the cellular and molecular level. Comparisons can be ambiguous when vectors harboring a transcription factor cDNA have differing extents and duration of gene expression. In view of the remarkable capacity of lentiviral vector (LV) for delivering and integrating transgene into both dividing and nondividing cells, we transduced rat hepatic stem cell-like WB cells with LV-Pdx1 or LV-Pdx1-VP16, and then used the limiting-dilution technique to clone single-cell-derived cell lines that stably express either Pdx1 or Pdx1-VP16. With these cell lines, we studied: (a) the expression of Pdx1 or Pdx1-VP16 protein by Western blotting and immunocytochemistry; (b) the repertoire of long-term expression of Pdx1- or Pdx1-VP16-induced pancreatic gene expression using RT-PCR methods; and (c) their capacity to serve as beta-cell surrogates in restoring euglycemia in streptozotocin-treated diabetic mice. We found that cell lines expressing either Pdx1 or Pdx1-VP16 long-term exhibited similar profiles for expression of genes related to pancreatic development and beta-cell function, and reversed hyperglycemia in diabetic mice. We also examined short-term expression of Pdx1 or Pdx1-VP16, and the results demonstrated that expression of Pdx1-VP16 is more efficient in initiating liver-to-endocrine pancreas transdifferentiation. Our findings demonstrate: (a) that the LV system is highly effective in producing persistent expression of Pdx1 or Pdx1-VP16 in WB hepatic cells; and (b) long-term, persistent expression of either Pdx1 or Pdx1-VP16 is similarly effective in converting hepatic stem cells into pancreatic endocrine precursor cells that, upon transplantation into diabetic mice, become functional insulin-producing cells and restore euglycemia.

Direct Differentiation of Hepatic Stem-Like WB Cells into Insulin-Producing Cells Using Small Molecules

Small Molecules Induced Hepatic Epithelial-Like Stem Cells WB Cells Expression of PDX1 in Vitro

The reprogrammed pancreatic progenitor-like intermediate state of hepatic cells is more susceptible to pancreatic beta cell differentiation.

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages

Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors

Chemical Strategies for Pancreatic Β Cell Differentiation, Reprogramming, and Regeneration

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Induction of Hepatocytes-Derived Insulin-Producing Cells Using Small Molecules and Identification of Microrna Profiles During This Procedure.

Transcription Factor Directed Differentiation of Human Embryonic Stem Cells into the Pancreatic Endocrine Lineage

Insulin-Secreting Cells Differentiation Derived from Human Embryonic Germ Cells

Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors

Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin A and all-trans retinoic acid

Partially Repair Damaged Islets Of Diabetic Rat Model Via Insulin-Producing Cells Differentiated From Human Umbilical Cord Mesenchymal Stem Cells Infusion

Morphological Characteristics and Identification of Islet-Like Cells Derived from Rat Adipose-Derived Stem Cells Cocultured with Pancreas Adult Stem Cells

Generating Insulin-Producing Cells for Diabetic Therapy: Existing Strategies and New Development

In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.

Optimization of Protocols for Generation of Insulin-Producing Cells from Human Embryonic Stem Cells Using Small Molecules

In Vivo And In Vitro Characterization Of Insulin-Producing Cells Obtained From Murine Bone Marrow

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Induction of embryonic stem cells differentiating into insulin-producing cells in vitro